These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39429679)

  • 1. Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database.
    Wu SN; Huang C; Wang YQ; Li X; Zhang SQ; Chen XD; Qin DY; Zhu L; Wen JY; Luo NC; Hu J; Liu Z
    Ther Adv Drug Saf; 2024; 15():20420986241285929. PubMed ID: 39429679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
    Oddone F; Kirwan J; Lopez-Lopez F; Zimina M; Fassari C; Holló G;
    Adv Ther; 2022 Aug; 39(8):3501-3521. PubMed ID: 35524840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
    Schwartz GF; Tan J; Kotak S
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension.
    Heo JH; Rascati KL; Wilson JP; Lawson KA; Richards KM; Nair R
    J Manag Care Spec Pharm; 2019 Sep; 25(9):1001-1010. PubMed ID: 31456491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy Loss Signal from Prostaglandin Eye Drop Use in Pregnancy: A Disproportionality Analysis Using Japanese and US Spontaneous Reporting Databases.
    Sakai T; Mori C; Koshiba H; Yuminaga R; Tanabe K; Ohtsu F
    Drugs Real World Outcomes; 2022 Mar; 9(1):43-51. PubMed ID: 34797554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension.
    Crichton AC; Vold S; Williams JM; Hollander DA
    Adv Ther; 2013 Mar; 30(3):260-70. PubMed ID: 23475405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients.
    Cai Z; Cao M; Liu K; Duan X
    J Ophthalmol; 2021; 2021():5586719. PubMed ID: 34123413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Pressure Elevation Associated with Topical Prostaglandin F2α Analogs: An Analysis of the Different Spontaneous Adverse Event Report Databases.
    Ohyama K; Kawakami H; Inoue M
    Biol Pharm Bull; 2017; 40(5):616-620. PubMed ID: 28458346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.
    Honrubia F; García-Sánchez J; Polo V; de la Casa JM; Soto J
    Br J Ophthalmol; 2009 Mar; 93(3):316-21. PubMed ID: 19019922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy.
    Reardon G; Schwartz GF; Kotak S
    BMC Ophthalmol; 2010 Mar; 10():5. PubMed ID: 20196848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
    Li N; Chen XM; Zhou Y; Wei ML; Yao X
    Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
    Reardon G; Schwartz GF; Mozaffari E
    Clin Ther; 2003 Apr; 25(4):1172-85. PubMed ID: 12809964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis.
    Tang W; Zhang F; Liu K; Duan X
    Medicine (Baltimore); 2019 Jul; 98(30):e16597. PubMed ID: 31348303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis.
    Walt JG; Wilensky JT; Fiscella R; Chiang TH; Guckian A
    Clin Drug Investig; 2007; 27(12):819-25. PubMed ID: 18020539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of topical prostaglandin therapy on corneal layers thickness in primary open-angle glaucoma patients using anterior segment optical coherence tomography.
    Eraslan N; Celikay O
    Int Ophthalmol; 2023 Sep; 43(9):3175-3184. PubMed ID: 37067694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
    Gagliuso DJ; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.